Ocular Findings in Women With Primary Antiphospholipid Syndrome
- Conditions
- Primary Antiphospholipid Syndrome
- Registration Number
- NCT03459508
- Lead Sponsor
- Cairo University
- Brief Summary
Antiphospholipid antibody syndrome (APS) is an autoimmune disease characterized by systemic thrombosis and bad obstetric history. APS secondary to another medical disorder is the most common. Visual and ocular changes e.g. vaso-occlusive disease of retinal and choroidal vessels are found in patients with secondary APS. Patients with primary APS have also been reported to have ocular changes e.g. retinal vascular occlusion
The aim of our study to detect prevalence of ocular changes in women diagnosed with primary APS and correlation of these changes with adverse obstetric outcome. If a correlation is present, ocular findings in women with APS could be used in the future as a predictor for poor obstetric outcome.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 50
- Age: 18 to 35 years
- Females with primary antiphospholipid syndrome
- Age: below 18 years and above 35 years
- Auto-immune diseases e.g. SLE and other connective tissue disease
- Medical diseases causing retinal vascular changes e.g. hypertension, diabetes mellitus, sickle cell anemia.
- Previous vitreo-retinal surgery
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The incidence of Ocular changes in females with antiphospholipid syndrome On the same day of enrollment into the study Number of participants with ocular findings detected by ophthalmological examination
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Cairo University
🇪🇬Cairo, Egypt
Cairo University🇪🇬Cairo, Egypt